Cardiac and pulmonary late effects do not negatively influence performance status and non-relapse mortality of children surviving five yr after autologous hematopoietic cell transplantation: Report from the EBMT Paediatric Diseases and Late Effects Working Parties

Pediatric Transplantation

Volumn 13, Issue 6, 2009, Pages 719-724

  Uderzo, Cornelio ^a   Pillon, Marta ^b   Tridello, Gloria ^b   Dini, Giorgio ^c   Urban, Christian ^d   Corti, Paola ^a   Zintl, Felix ^e   Fagioli, Franca ^f   Messina, Chiara ^b   Verdeguer, Amparo ^g   Faraci, Maura ^c   Fedeli, Sara ^a   Tana, Francesco ^h   Tichelli, André ⁱ   Passweg, Jakob ^j   Rovelli, Attilio ^a  

^a SAN GERARDO HOSPITAL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d Universitatsklinik fur Kinder und Jugendheilkunde Graz   (Austria)

^e FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^f UNIVERSITY OF TURIN   (Italy)

^g HOSPITAL INFANTIL LA FE   (Spain)

^h UNIVERSITY OF MILANO BICOCCA   (Italy)

ⁱ UNIVERSITY HOSPITAL BASEL   (Switzerland)

^j GENEVA UNIVERSITY HOSPITALS   (Switzerland)

more..

Author keywords

Autologous hematopoietic cell transplantation; Cardiac late effects; Childhood; Performance status; Pulmonary

Indexed keywords

ANTHRACYCLINE DERIVATIVE; BUSULFAN; CYCLOPHOSPHAMIDE; ETOPOSIDE; MELPHALAN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHILD; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEART DISEASE; HEART FUNCTION; HUMAN; LUNG DISEASE; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELODYSPLASTIC SYNDROME; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; RELAPSE; SCHOOL CHILD; SURVIVOR; VITAL CAPACITY; WHOLE BODY RADIATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HEART; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; INFANT; LUNG; MALE; PEDIATRICS; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 68849120961     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.01055.x     Document Type: Article

References (18)

1. Ness KK, Bhatia S, Baker KS, et al. Performance limitations and participation restrictions among childhood cancer survivors treated with hematopoietic stem cell transplantation. Arch Pediatr Adolesc Med 2005 : 159 : 706 713.
2. Uderzo C, Pillon M, Tridello G, et al. Impact of anthracycline dose, preparative regimen and chronic graft-versus-host-disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: A prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties. Bone Marrow Transplant 2007 : 39 : 667 675.
3. Hankinson JL, Bang KM. Acceptability and reproducibility criteria of the American Thoracic Society as observed in a sample of a general population. Am Rev Resp Dis 1991 : 143 : 516 525.
4. Gardner RM, Hankinson JL, Clausen L, et al. Standardisation of spirometry: 1987 Update. Official statement of the American Thoracic Society. Am Rev Resp Dis 1987 : 136 : 1285 1298.
5. Rovelli A, Pezzini C, Silvestri D, et al. Cardiac and respiratory function after bone marrow transplantation in children with leukemia. Bone Marrow Transplant 1995 : 16 : 571 576.
6. Blume KG, Amylon MD. The evaluation and counseling of candidates for hematopoietic cell transplantation. In : Blume KG, Forman SJ, Appelbaum FR, eds. Thomas' Hematopoietic Cell Transplantation, 3rd edn. Blackwell Science, Malden, MA : 2004 449 461.
7. Marubini E, Valsecchi MG. Analysing Survival Data from Clinical Trials and Observational Studies. Chichester, NY : Wiley & Sons, 1995.
8. Armitage P. Statistica Medica: Metodi Statistici per la Ricerca in Medicina. Italy : Edizioni Feltrinelli, 1985.
9. De Wolf D, Suys B, Maurus R, et al. Dobutamine stress echocardiography in the evaluation of late anthracycline cardiotoxicity in childhood cancer survivors. Pediatr Res 1996 : 39 : 504 512.
10. Hogarty AN, Leahey A, Zhao H, et al. Longitudinal evaluation of cardiopulmonary performance during exercise after bone marrow transplantation in children. J Pediatr 2000 : 136 : 311 317.
11. Tang WHW, Thomas S, Kalaycio M, et al. Clinical outcomes of patients with impaired left ventricular ejection fraction undergoing autologous bone marrow transplantation: Can we safely transplant with impaired ejection fraction? Bone Marrow Transplant 2004 : 34 : 603 607.
12. Rizzo JD, Wingard JR, Tichelli A, et al. Recommended screening and preventive practice for long-term survivors after hematopoietic cell transplantation: Joint recommendations of the European Group for Blood and Marrow Transplantation Centers for International Blood and Marrow research and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT). Bone Marrow Transplant 2006 : 37 : 249 261.
13. Baker KS, Ness KK, Steinberger J, et al. Diabetes, hypertension and cardiovascular events in survivors of hematopoietic cell transplantation: A report from the bone marrow transplantation survivor study. Blood 2007 : 109 : 1765 1772.
14. Bluhm EC, Ronckers C, Hayashi R, et al. Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: A report from the Childhood Cancer Survivor Study. Blood 2008 : 111 : 4014 4021.
15. Bhatia S, Robison LL, Francisco L, Carter A, et al. Late mortality in survivors of autologous hematopoietic-cell transplantation: Report from the bone marrow transplant survivor study. Blood 2005 : 105 : 4215 4223.
16. Syrjala KL, Langer SL, Abrams JR, Storer BE, Martin PJ. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol 2005 : 23 : 6596 6606.
17. Crawford SW, Pepe M, Lin D, Benedetti F, Deeg HJ. Abnormalities of pulmonary function tests after bone marrow transplantation predict non relapse mortality. Am J Respir Crit Care Med 1995 : 152 : 690 695.
18. Chien JW, Martin PJ, Gooley TA, et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003 : 168 : 208 214.